日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial

信迪利单抗诱导治疗在潜在可切除的 III 期非小细胞肺癌中的疗效和安全性（LungMate-009）：一项开放标签的 II 期试验

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103669
Ge, Tao; Zhang, Hongyi; Zhu, Xinsheng; Teng, Meixin; Zhou, Yifei; Wang, Suyu; Bian, Dongliang; Zhang, Lele; Hu, Haiyang; Guo, Qiji; Su, Jincheng; Hu, Shiqi; Yu, Huansha; Zhou, Yirui; Huang, Jie; Yang, Jie; Zhu, Yuming; Bao, Yi; Bao, Minwei; Hu, Xuefei; He, Wenxin; Zhang, Peng
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Neoadjuvant camrelizumab plus chemotherapy or apatinib for resectable stage IIA-IIIA NSCLC: a multicenter, two-arm, phase II exploratory trial

新辅助卡瑞利珠单抗联合化疗或阿帕替尼治疗可切除的 IIA-IIIA 期非小细胞肺癌：一项多中心、双臂、II 期探索性试验

期刊:BMC Medicine
影响因子:8.3
doi:10.1186/s12916-025-04250-4
Ji, Shuyu; Sheng, Zhenxin; Bian, Dongliang; Bao, Minwei; Jin, Kaiqi; Zhang, Wentian; Zhu, Xinsheng; Sun, Fenghuan; Xia, Haoran; Zhang, Han; Shen, Ziyun; Yu, Huansha; Zhang, Lele; Huang, Jie; Peng, Zhang; Song, Nan; Wang, Haifeng; Qian, Biyun; Zhu, Yuming
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Selective inhibition of TGF-β-induced epithelial-mesenchymal transition overcomes chemotherapy resistance in high-risk lung squamous cell carcinoma.

选择性抑制 TGF-β 诱导的上皮-间质转化可克服高危肺鳞状细胞癌的化疗耐药性

期刊:Communications Biology
影响因子:5.1
doi:10.1038/s42003-025-07595-x
Sun Liangdong, Wang Jue, Yu Huansha, Zhu Xinsheng, Zhang Jing, Hu Junjie, Yan Yilv, Zhang Xun, Zhu Yuming, Jiang Gening, Ding Ming, Zhang Peng, Zhang Lele
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II-III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study

新辅助卡瑞利珠单抗（一种抗PD-1抗体）联合化疗或阿帕替尼（一种VEGFR-2抑制剂）治疗初始不可切除的II-III期非小细胞肺癌：一项多中心、双臂、II期探索性研究

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-024-01861-w
Xia, Haoran; Zhang, Han; Ruan, Zheng; Zhang, Huibiao; Sun, Liangdong; Chen, Hezhong; Zhou, Yongxin; Zhang, Lele; Bian, Dongliang; Zhu, Xinsheng; Zhang, Jing; Sun, Fenghuan; Yu, Huansha; Song, Nan; Liu, Xiaogang; Zhu, Yuming; Zhang, Haiping; He, Wenxin; Chen, Jian; Yang, Jie; Chen, Guohan; Xie, Shiliang; Tang, Dongfang; Zhang, Xiaomiao; Duan, Liang; Zhao, Deping; Li, Qinchuan; Zhang, Peng; Jiang, Gening
肺癌
肿瘤
肿瘤免疫
细胞生物学
EGF
EGFR
VEGF
PD-1
发表日期：2024
文献求助 收藏

Enhancing the differential diagnosis of small pulmonary nodules: a comprehensive model integrating plasma methylation, protein biomarkers, and LDCT imaging features

提高小肺结节的鉴别诊断水平：整合血浆甲基化、蛋白质生物标志物和低剂量CT成像特征的综合模型

期刊:Journal of Translational Medicine
影响因子:7.5
doi:10.1186/s12967-024-05723-5
Yang, Meng; Yu, Huansha; Feng, Hongxiang; Duan, Jianghui; Wang, Kaige; Tong, Bing; Zhang, Yunzhi; Li, Wei; Wang, Ye; Liang, Chaoyang; Sun, Hongliang; Zhong, Dingrong; Wang, Bei; Chen, Huang; Gong, Chengxiang; He, Qiye; Su, Zhixi; Liu, Rui; Zhang, Peng
表观遗传
发表日期：2024
文献求助 收藏

Prognostic factors of resectable anaplastic lymphoma kinase (ALK)-rearranged non-small cell lung cancer (NSCLC) patients: a retrospective analysis based on a single center

可切除的间变性淋巴瘤激酶（ALK）重排非小细胞肺癌（NSCLC）患者的预后因素：基于单中心的回顾性分析

期刊:Translational Lung Cancer Research
影响因子:3.5
doi:10.21037/tlcr-23-606
Zeng, Ao; Xiong, Yicheng; Zhang, Jing; Yu, Huansha; Zhang, Lele; Bian, Dongliang; Han, Lu; Wang, Jue; Chen, Yan; Shaik, Mohammed Saud; Zhang, Peng; Dai, Jie
肺癌
肿瘤
肿瘤免疫
信号转导
ALK
淋巴瘤
CLC
细胞生物学
发表日期：2024
文献求助 收藏

Optimal surgical timing for lung cancer following SARS-CoV-2 infection: a prospective multicenter cohort study

SARS-CoV-2感染后肺癌的最佳手术时机：一项前瞻性多中心队列研究

期刊:BMC Cancer
影响因子:3.4
doi:10.1186/s12885-024-13020-z
Shen, Ziyun; Huang, Zhihua; Zhu, Tieyuan; Zhang, Jing; Teng, Meixin; Qing, Yang; Hu, Shiqi; Li, Yang; Xiong, Yanzheng; Shen, Jie; Huang, Yiwen; Zhang, Lele; Yu, Huansha; Chen, Jian; Ma, Dongchun; Geng, Qing; Luo, Yan; Jiang, Gening; Zhang, Peng
SARS-CoV-2
肺癌
肿瘤
肿瘤免疫
炎症/感染
发表日期：2024
文献求助 收藏

The impact of oncogenic driver mutations on neoadjuvant immunotherapy outcomes in patients with resectable non-small cell lung cancer

致癌驱动基因突变对可切除非小细胞肺癌患者新辅助免疫治疗疗效的影响

期刊:Cancer Immunology Immunotherapy
影响因子:5.1
doi:10.1007/s00262-023-03560-x
Shen, Ziyun; Teng, Meixin; Han, Lu; Bian, Dongliang; Zhang, Jing; Zhu, Xinsheng; Qing, Yang; Hu, Shiqi; Chen, Yan; Yao, Wangchao; Yu, Huansha; Zhang, Lele; Zhang, Peng
肺癌
肿瘤
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Significance of spread through air spaces in small cell lung cancer

小细胞肺癌经气腔扩散的意义

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-022-04462-8
Han, Lu; Huang, Zhida; Zhang, Jing; Chen, Yan; Wang, Jue; Xiong, Yicheng; Yao, Wangchao; Hou, Likun; Zhang, Liping; Yu, Huansha; Song, Nan; Zhang, Zhonghong; Zhu, Yuming
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

The efficacy and safety of wedge resection for peripheral stage IA lung adenocarcinoma: a real-world study based on a single center

楔形切除术治疗外周型IA期肺腺癌的疗效和安全性：一项基于单中心的真实世界研究

期刊:Journal of Thoracic Disease
影响因子:1.9
doi:10.21037/jtd-22-1010
Bian, Dongliang; Xiong, Yicheng; Jin, Kaiqi; Zhu, Yuming; Yu, Huansha; Dai, Jie; Jiang, Gening
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏